Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lead Real Estate ADR | LRE | Dec 24, 2024 | 1.92 | +2.21 |
Leafly | LFLY | Dec 24, 2024 | 1.75 | +10.06 |
Leap Therapeutics | LPTX | Dec 24, 2024 | 2.91 | +0.69 |
Lear | LEA | Dec 24, 2024 | 95.18 | +0.69 |
LeddarTech | LDTC | Dec 24, 2024 | 0.80 | +1.27 |
Lee Enterprises | LEE | Dec 24, 2024 | 14.64 | -2.47 |
Legacy Housing | LEGH | Dec 24, 2024 | 24.91 | +0.57 |
LegalZoom.com | LZ | Dec 24, 2024 | 7.83 | +0.77 |
Legato Merger III | LEGT | Dec 24, 2024 | 10.29 | -0.10 |
Legend Biotech ADR | LEGN | Dec 24, 2024 | 32.80 | -3.33 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Dec 24, 2024 | 38.96 | +0.75 |
Leggett & Platt | LEG | Dec 24, 2024 | 9.72 | -0.61 |
Leidos | LDOS | Dec 24, 2024 | 145.58 | +0.26 |
Leishen Energy Holding Co., Ltd. - Ordinary Shares | LSE | Dec 24, 2024 | 5.00 | 0.00 |
LeMaitre Vascular | LMAT | Dec 24, 2024 | 92.63 | +1.37 |
Lemonade | LMND | Dec 24, 2024 | 41.27 | +3.43 |
LendingClub | LC | Dec 24, 2024 | 16.66 | +2.08 |
LendingTree | TREE | Dec 24, 2024 | 38.44 | +0.44 |
Lendway | LDWY | Dec 24, 2024 | 4.54 | -9.20 |
Lennar A | LEN | Dec 24, 2024 | 138.00 | 0.00 |
Lennar B | LEN-B | Dec 24, 2024 | 134.17 | +0.27 |
Lennox International | LII | Dec 24, 2024 | 631.13 | +0.97 |
LENSAR | LNSR | Dec 24, 2024 | 8.69 | +0.46 |
LENZ Therapeutics | LENZ | Dec 24, 2024 | 31.50 | +0.64 |
Leonardo DRS | DRS | Dec 24, 2024 | 33.02 | +0.61 |
Lesaka Technologies | LSAK | Dec 24, 2024 | 5.16 | +1.98 |
Leslies | LESL | Dec 24, 2024 | 2.18 | 0.00 |
Levi Strauss & Co A | LEVI | Dec 24, 2024 | 17.44 | +0.69 |
Lexaria Bioscience | LEXX | Dec 24, 2024 | 2.21 | +0.45 |
Lexeo Therapeutics | LXEO | Dec 24, 2024 | 6.35 | +2.25 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.